nodes	percent_of_prediction	percent_of_DWPC	metapath
Zidovudine—CYP2A6—esophageal cancer	0.272	0.729	CbGaD
Zidovudine—ABCC5—Cisplatin—esophageal cancer	0.106	0.254	CbGbCtD
Zidovudine—ABCB1—esophageal cancer	0.101	0.271	CbGaD
Zidovudine—SLC22A2—Cisplatin—esophageal cancer	0.0371	0.089	CbGbCtD
Zidovudine—SLC22A11—Methotrexate—esophageal cancer	0.0355	0.0852	CbGbCtD
Zidovudine—SLC22A7—Methotrexate—esophageal cancer	0.0339	0.0812	CbGbCtD
Zidovudine—ABCC4—Methotrexate—esophageal cancer	0.0331	0.0793	CbGbCtD
Zidovudine—ABCG2—Carboplatin—esophageal cancer	0.0321	0.0769	CbGbCtD
Zidovudine—ABCG2—Cisplatin—esophageal cancer	0.0274	0.0657	CbGbCtD
Zidovudine—SLC22A8—Methotrexate—esophageal cancer	0.0207	0.0496	CbGbCtD
Zidovudine—CYP2C9—Capecitabine—esophageal cancer	0.0202	0.0485	CbGbCtD
Zidovudine—ABCG2—Methotrexate—esophageal cancer	0.0178	0.0427	CbGbCtD
Zidovudine—SLC22A6—Methotrexate—esophageal cancer	0.0144	0.0345	CbGbCtD
Zidovudine—ALB—Methotrexate—esophageal cancer	0.0123	0.0294	CbGbCtD
Zidovudine—CYP2C9—Cisplatin—esophageal cancer	0.0102	0.0244	CbGbCtD
Zidovudine—ABCB1—Cisplatin—esophageal cancer	0.00988	0.0237	CbGbCtD
Zidovudine—ABCB1—Methotrexate—esophageal cancer	0.00641	0.0154	CbGbCtD
Zidovudine—Floxuridine—TYMP—esophageal cancer	0.00277	0.557	CrCbGaD
Zidovudine—TERT—epithelium—esophageal cancer	0.00265	0.115	CbGeAlD
Zidovudine—Trifluridine—TYMP—esophageal cancer	0.0022	0.443	CrCbGaD
Zidovudine—SLC28A1—digestive system—esophageal cancer	0.00205	0.0888	CbGeAlD
Zidovudine—TERT—digestive system—esophageal cancer	0.00202	0.0872	CbGeAlD
Zidovudine—TK1—epithelium—esophageal cancer	0.00182	0.0789	CbGeAlD
Zidovudine—TERT—lung—esophageal cancer	0.00168	0.0728	CbGeAlD
Zidovudine—TK1—digestive system—esophageal cancer	0.00139	0.06	CbGeAlD
Zidovudine—TK1—lung—esophageal cancer	0.00116	0.0501	CbGeAlD
Zidovudine—ABCC5—bronchus—esophageal cancer	0.000802	0.0347	CbGeAlD
Zidovudine—TK1—lymph node—esophageal cancer	0.000792	0.0343	CbGeAlD
Zidovudine—UGT2B7—digestive system—esophageal cancer	0.000775	0.0335	CbGeAlD
Zidovudine—SLC22A11—digestive system—esophageal cancer	0.000755	0.0327	CbGeAlD
Zidovudine—SLC22A7—digestive system—esophageal cancer	0.000737	0.0319	CbGeAlD
Zidovudine—SLC22A2—digestive system—esophageal cancer	0.000656	0.0284	CbGeAlD
Zidovudine—SLC29A2—lymph node—esophageal cancer	0.000655	0.0283	CbGeAlD
Zidovudine—ABCC4—bronchus—esophageal cancer	0.000556	0.024	CbGeAlD
Zidovudine—Pain—Carboplatin—esophageal cancer	0.000548	0.00866	CcSEcCtD
Zidovudine—Tongue disorder—Capecitabine—esophageal cancer	0.000534	0.00844	CcSEcCtD
Zidovudine—Hepatocellular injury—Cisplatin—esophageal cancer	0.000527	0.00832	CcSEcCtD
Zidovudine—ABCC5—lung—esophageal cancer	0.000517	0.0224	CbGeAlD
Zidovudine—Wheezing—Cisplatin—esophageal cancer	0.000512	0.00808	CcSEcCtD
Zidovudine—Rash erythematous—Capecitabine—esophageal cancer	0.000507	0.00801	CcSEcCtD
Zidovudine—Body temperature increased—Carboplatin—esophageal cancer	0.000507	0.008	CcSEcCtD
Zidovudine—Fluid retention—Cisplatin—esophageal cancer	0.0005	0.0079	CcSEcCtD
Zidovudine—Hyperaesthesia—Capecitabine—esophageal cancer	0.000495	0.00782	CcSEcCtD
Zidovudine—Neuropathy—Cisplatin—esophageal cancer	0.000495	0.00781	CcSEcCtD
Zidovudine—Rhinorrhoea—Capecitabine—esophageal cancer	0.000479	0.00757	CcSEcCtD
Zidovudine—Rigors—Capecitabine—esophageal cancer	0.000476	0.00751	CcSEcCtD
Zidovudine—Dysphonia—Capecitabine—esophageal cancer	0.000472	0.00746	CcSEcCtD
Zidovudine—CYP2A6—lung—esophageal cancer	0.000464	0.0201	CbGeAlD
Zidovudine—Hypoxia—Methotrexate—esophageal cancer	0.000455	0.00719	CcSEcCtD
Zidovudine—Phlebitis—Cisplatin—esophageal cancer	0.000444	0.00701	CcSEcCtD
Zidovudine—Polyuria—Cisplatin—esophageal cancer	0.000436	0.00688	CcSEcCtD
Zidovudine—Skin discolouration—Capecitabine—esophageal cancer	0.00043	0.00679	CcSEcCtD
Zidovudine—Rectal haemorrhage—Capecitabine—esophageal cancer	0.00043	0.00679	CcSEcCtD
Zidovudine—ABCC4—digestive system—esophageal cancer	0.000429	0.0186	CbGeAlD
Zidovudine—Bone marrow depression—Methotrexate—esophageal cancer	0.000428	0.00677	CcSEcCtD
Zidovudine—Deafness—Cisplatin—esophageal cancer	0.000428	0.00675	CcSEcCtD
Zidovudine—Hyperbilirubinaemia—Capecitabine—esophageal cancer	0.000427	0.00675	CcSEcCtD
Zidovudine—Liver disorder—Methotrexate—esophageal cancer	0.000424	0.0067	CcSEcCtD
Zidovudine—Haemolytic anaemia—Cisplatin—esophageal cancer	0.000424	0.00669	CcSEcCtD
Zidovudine—Cardiac failure congestive—Cisplatin—esophageal cancer	0.000422	0.00666	CcSEcCtD
Zidovudine—Hearing impaired—Capecitabine—esophageal cancer	0.000408	0.00645	CcSEcCtD
Zidovudine—Fluid retention—Capecitabine—esophageal cancer	0.000369	0.00582	CcSEcCtD
Zidovudine—Irritability—Cisplatin—esophageal cancer	0.000365	0.00577	CcSEcCtD
Zidovudine—Neuropathy—Capecitabine—esophageal cancer	0.000365	0.00576	CcSEcCtD
Zidovudine—ABCC4—lung—esophageal cancer	0.000359	0.0155	CbGeAlD
Zidovudine—CYP2C19—digestive system—esophageal cancer	0.000357	0.0155	CbGeAlD
Zidovudine—ABCC5—lymph node—esophageal cancer	0.000354	0.0153	CbGeAlD
Zidovudine—Mouth ulceration—Capecitabine—esophageal cancer	0.000351	0.00555	CcSEcCtD
Zidovudine—Urine output increased—Capecitabine—esophageal cancer	0.000351	0.00555	CcSEcCtD
Zidovudine—Breast disorder—Cisplatin—esophageal cancer	0.000346	0.00546	CcSEcCtD
Zidovudine—Aspartate aminotransferase increased—Cisplatin—esophageal cancer	0.000344	0.00544	CcSEcCtD
Zidovudine—Nasopharyngitis—Cisplatin—esophageal cancer	0.000342	0.0054	CcSEcCtD
Zidovudine—Phlebitis—Capecitabine—esophageal cancer	0.000327	0.00517	CcSEcCtD
Zidovudine—Pancreatitis—Cisplatin—esophageal cancer	0.000324	0.00512	CcSEcCtD
Zidovudine—Sweating increased—Cisplatin—esophageal cancer	0.000322	0.00509	CcSEcCtD
Zidovudine—Polyuria—Capecitabine—esophageal cancer	0.000321	0.00507	CcSEcCtD
Zidovudine—Skin discolouration—Methotrexate—esophageal cancer	0.00032	0.00506	CcSEcCtD
Zidovudine—Hyperbilirubinaemia—Methotrexate—esophageal cancer	0.000318	0.00502	CcSEcCtD
Zidovudine—Deafness—Capecitabine—esophageal cancer	0.000315	0.00498	CcSEcCtD
Zidovudine—Pancytopenia—Cisplatin—esophageal cancer	0.000314	0.00496	CcSEcCtD
Zidovudine—Haemolytic anaemia—Capecitabine—esophageal cancer	0.000312	0.00493	CcSEcCtD
Zidovudine—Vasculitis—Methotrexate—esophageal cancer	0.000296	0.00468	CcSEcCtD
Zidovudine—Neuropathy peripheral—Cisplatin—esophageal cancer	0.000289	0.00456	CcSEcCtD
Zidovudine—Stomatitis—Cisplatin—esophageal cancer	0.000287	0.00454	CcSEcCtD
Zidovudine—Cystitis noninfective—Methotrexate—esophageal cancer	0.000282	0.00446	CcSEcCtD
Zidovudine—Cystitis—Methotrexate—esophageal cancer	0.000279	0.00441	CcSEcCtD
Zidovudine—Hepatobiliary disease—Cisplatin—esophageal cancer	0.000279	0.0044	CcSEcCtD
Zidovudine—CYP2C9—digestive system—esophageal cancer	0.000277	0.012	CbGeAlD
Zidovudine—Aplastic anaemia—Methotrexate—esophageal cancer	0.000271	0.00429	CcSEcCtD
Zidovudine—Irritability—Capecitabine—esophageal cancer	0.000269	0.00425	CcSEcCtD
Zidovudine—Mood swings—Capecitabine—esophageal cancer	0.000267	0.00422	CcSEcCtD
Zidovudine—Urine output increased—Methotrexate—esophageal cancer	0.000261	0.00413	CcSEcCtD
Zidovudine—Mouth ulceration—Methotrexate—esophageal cancer	0.000261	0.00413	CcSEcCtD
Zidovudine—Bladder pain—Methotrexate—esophageal cancer	0.000261	0.00413	CcSEcCtD
Zidovudine—Urinary tract disorder—Cisplatin—esophageal cancer	0.000261	0.00413	CcSEcCtD
Zidovudine—Connective tissue disorder—Cisplatin—esophageal cancer	0.00026	0.00411	CcSEcCtD
Zidovudine—Urethral disorder—Cisplatin—esophageal cancer	0.000259	0.0041	CcSEcCtD
Zidovudine—Gynaecomastia—Methotrexate—esophageal cancer	0.000259	0.00409	CcSEcCtD
Zidovudine—Breast disorder—Capecitabine—esophageal cancer	0.000255	0.00402	CcSEcCtD
Zidovudine—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.000254	0.00401	CcSEcCtD
Zidovudine—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.000254	0.00401	CcSEcCtD
Zidovudine—ALB—lymph node—esophageal cancer	0.000253	0.011	CbGeAlD
Zidovudine—ABCG2—lung—esophageal cancer	0.000253	0.011	CbGeAlD
Zidovudine—Nasopharyngitis—Capecitabine—esophageal cancer	0.000252	0.00398	CcSEcCtD
Zidovudine—Lymphadenopathy—Methotrexate—esophageal cancer	0.000246	0.00389	CcSEcCtD
Zidovudine—Cardiac disorder—Cisplatin—esophageal cancer	0.000246	0.00388	CcSEcCtD
Zidovudine—ABCC4—lymph node—esophageal cancer	0.000245	0.0106	CbGeAlD
Zidovudine—Dysphagia—Capecitabine—esophageal cancer	0.000244	0.00385	CcSEcCtD
Zidovudine—Influenza—Capecitabine—esophageal cancer	0.000244	0.00385	CcSEcCtD
Zidovudine—Polyuria—Methotrexate—esophageal cancer	0.000239	0.00378	CcSEcCtD
Zidovudine—Mediastinal disorder—Cisplatin—esophageal cancer	0.000238	0.00377	CcSEcCtD
Zidovudine—Sweating increased—Capecitabine—esophageal cancer	0.000237	0.00375	CcSEcCtD
Zidovudine—Pancytopenia—Capecitabine—esophageal cancer	0.000231	0.00366	CcSEcCtD
Zidovudine—Erythema—Cisplatin—esophageal cancer	0.00023	0.00364	CcSEcCtD
Zidovudine—Malnutrition—Cisplatin—esophageal cancer	0.00023	0.00364	CcSEcCtD
Zidovudine—Dysuria—Capecitabine—esophageal cancer	0.000228	0.0036	CcSEcCtD
Zidovudine—Neutropenia—Capecitabine—esophageal cancer	0.000228	0.0036	CcSEcCtD
Zidovudine—Flatulence—Cisplatin—esophageal cancer	0.000227	0.00359	CcSEcCtD
Zidovudine—Muscle spasms—Cisplatin—esophageal cancer	0.000221	0.0035	CcSEcCtD
Zidovudine—Weight decreased—Capecitabine—esophageal cancer	0.00022	0.00348	CcSEcCtD
Zidovudine—Tremor—Cisplatin—esophageal cancer	0.000216	0.00341	CcSEcCtD
Zidovudine—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000215	0.0034	CcSEcCtD
Zidovudine—Ill-defined disorder—Cisplatin—esophageal cancer	0.000214	0.00338	CcSEcCtD
Zidovudine—Neuropathy peripheral—Capecitabine—esophageal cancer	0.000213	0.00336	CcSEcCtD
Zidovudine—Anaemia—Cisplatin—esophageal cancer	0.000213	0.00336	CcSEcCtD
Zidovudine—Stomatitis—Capecitabine—esophageal cancer	0.000212	0.00335	CcSEcCtD
Zidovudine—Jaundice—Capecitabine—esophageal cancer	0.000212	0.00335	CcSEcCtD
Zidovudine—CYP3A4—digestive system—esophageal cancer	0.000211	0.00913	CbGeAlD
Zidovudine—Malaise—Cisplatin—esophageal cancer	0.000208	0.00328	CcSEcCtD
Zidovudine—Haematuria—Capecitabine—esophageal cancer	0.000207	0.00327	CcSEcCtD
Zidovudine—Leukopenia—Cisplatin—esophageal cancer	0.000206	0.00326	CcSEcCtD
Zidovudine—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000205	0.00325	CcSEcCtD
Zidovudine—Epistaxis—Capecitabine—esophageal cancer	0.000205	0.00324	CcSEcCtD
Zidovudine—Agranulocytosis—Capecitabine—esophageal cancer	0.000203	0.0032	CcSEcCtD
Zidovudine—Irritability—Methotrexate—esophageal cancer	0.0002	0.00316	CcSEcCtD
Zidovudine—Convulsion—Cisplatin—esophageal cancer	0.0002	0.00315	CcSEcCtD
Zidovudine—Mood swings—Methotrexate—esophageal cancer	0.000199	0.00314	CcSEcCtD
Zidovudine—ABCB1—epithelium—esophageal cancer	0.000196	0.0085	CbGeAlD
Zidovudine—Myalgia—Cisplatin—esophageal cancer	0.000196	0.0031	CcSEcCtD
Zidovudine—Rhinitis—Capecitabine—esophageal cancer	0.000196	0.00309	CcSEcCtD
Zidovudine—Anxiety—Cisplatin—esophageal cancer	0.000195	0.00309	CcSEcCtD
Zidovudine—Hepatitis—Capecitabine—esophageal cancer	0.000195	0.00308	CcSEcCtD
Zidovudine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000195	0.00308	CcSEcCtD
Zidovudine—Discomfort—Cisplatin—esophageal cancer	0.000194	0.00306	CcSEcCtD
Zidovudine—Pharyngitis—Capecitabine—esophageal cancer	0.000194	0.00306	CcSEcCtD
Zidovudine—Urinary tract disorder—Capecitabine—esophageal cancer	0.000193	0.00304	CcSEcCtD
Zidovudine—Connective tissue disorder—Capecitabine—esophageal cancer	0.000192	0.00303	CcSEcCtD
Zidovudine—Urethral disorder—Capecitabine—esophageal cancer	0.000191	0.00302	CcSEcCtD
Zidovudine—Breast disorder—Methotrexate—esophageal cancer	0.00019	0.003	CcSEcCtD
Zidovudine—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.000189	0.00299	CcSEcCtD
Zidovudine—Oedema—Cisplatin—esophageal cancer	0.000188	0.00297	CcSEcCtD
Zidovudine—Anaphylactic shock—Cisplatin—esophageal cancer	0.000188	0.00297	CcSEcCtD
Zidovudine—Erythema multiforme—Capecitabine—esophageal cancer	0.000184	0.00291	CcSEcCtD
Zidovudine—Nervous system disorder—Cisplatin—esophageal cancer	0.000184	0.00291	CcSEcCtD
Zidovudine—Thrombocytopenia—Cisplatin—esophageal cancer	0.000184	0.00291	CcSEcCtD
Zidovudine—Skin disorder—Cisplatin—esophageal cancer	0.000183	0.00288	CcSEcCtD
Zidovudine—Hyperhidrosis—Cisplatin—esophageal cancer	0.000182	0.00287	CcSEcCtD
Zidovudine—Cardiac disorder—Capecitabine—esophageal cancer	0.000181	0.00286	CcSEcCtD
Zidovudine—Anorexia—Cisplatin—esophageal cancer	0.000179	0.00283	CcSEcCtD
Zidovudine—Pancreatitis—Methotrexate—esophageal cancer	0.000178	0.00281	CcSEcCtD
Zidovudine—Mediastinal disorder—Capecitabine—esophageal cancer	0.000176	0.00278	CcSEcCtD
Zidovudine—Chills—Capecitabine—esophageal cancer	0.000175	0.00276	CcSEcCtD
Zidovudine—ABCB1—trachea—esophageal cancer	0.000174	0.00752	CbGeAlD
Zidovudine—ABCG2—lymph node—esophageal cancer	0.000173	0.00749	CbGeAlD
Zidovudine—Pancytopenia—Methotrexate—esophageal cancer	0.000172	0.00272	CcSEcCtD
Zidovudine—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000171	0.00271	CcSEcCtD
Zidovudine—Mental disorder—Capecitabine—esophageal cancer	0.000171	0.0027	CcSEcCtD
Zidovudine—Erythema—Capecitabine—esophageal cancer	0.00017	0.00268	CcSEcCtD
Zidovudine—Malnutrition—Capecitabine—esophageal cancer	0.00017	0.00268	CcSEcCtD
Zidovudine—Dysuria—Methotrexate—esophageal cancer	0.00017	0.00268	CcSEcCtD
Zidovudine—Neutropenia—Methotrexate—esophageal cancer	0.00017	0.00268	CcSEcCtD
Zidovudine—Paraesthesia—Cisplatin—esophageal cancer	0.000169	0.00267	CcSEcCtD
Zidovudine—Dyspnoea—Cisplatin—esophageal cancer	0.000168	0.00265	CcSEcCtD
Zidovudine—Flatulence—Capecitabine—esophageal cancer	0.000167	0.00264	CcSEcCtD
Zidovudine—Dysgeusia—Capecitabine—esophageal cancer	0.000166	0.00263	CcSEcCtD
Zidovudine—Back pain—Capecitabine—esophageal cancer	0.000164	0.00259	CcSEcCtD
Zidovudine—Decreased appetite—Cisplatin—esophageal cancer	0.000163	0.00258	CcSEcCtD
Zidovudine—Muscle spasms—Capecitabine—esophageal cancer	0.000163	0.00258	CcSEcCtD
Zidovudine—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000162	0.00256	CcSEcCtD
Zidovudine—Pain—Cisplatin—esophageal cancer	0.000161	0.00254	CcSEcCtD
Zidovudine—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.00016	0.00253	CcSEcCtD
Zidovudine—Tremor—Capecitabine—esophageal cancer	0.000159	0.00251	CcSEcCtD
Zidovudine—Stomatitis—Methotrexate—esophageal cancer	0.000158	0.00249	CcSEcCtD
Zidovudine—Ill-defined disorder—Capecitabine—esophageal cancer	0.000158	0.00249	CcSEcCtD
Zidovudine—Anaemia—Capecitabine—esophageal cancer	0.000157	0.00248	CcSEcCtD
Zidovudine—Sweating—Methotrexate—esophageal cancer	0.000155	0.00245	CcSEcCtD
Zidovudine—Feeling abnormal—Cisplatin—esophageal cancer	0.000155	0.00245	CcSEcCtD
Zidovudine—Haematuria—Methotrexate—esophageal cancer	0.000154	0.00244	CcSEcCtD
Zidovudine—Malaise—Capecitabine—esophageal cancer	0.000153	0.00242	CcSEcCtD
Zidovudine—Hepatobiliary disease—Methotrexate—esophageal cancer	0.000153	0.00242	CcSEcCtD
Zidovudine—Epistaxis—Methotrexate—esophageal cancer	0.000153	0.00241	CcSEcCtD
Zidovudine—Vertigo—Capecitabine—esophageal cancer	0.000153	0.00241	CcSEcCtD
Zidovudine—Syncope—Capecitabine—esophageal cancer	0.000152	0.00241	CcSEcCtD
Zidovudine—Leukopenia—Capecitabine—esophageal cancer	0.000152	0.0024	CcSEcCtD
Zidovudine—Agranulocytosis—Methotrexate—esophageal cancer	0.000151	0.00238	CcSEcCtD
Zidovudine—ABCB1—digestive system—esophageal cancer	0.000149	0.00647	CbGeAlD
Zidovudine—Loss of consciousness—Capecitabine—esophageal cancer	0.000149	0.00236	CcSEcCtD
Zidovudine—Body temperature increased—Cisplatin—esophageal cancer	0.000149	0.00235	CcSEcCtD
Zidovudine—Cough—Capecitabine—esophageal cancer	0.000148	0.00234	CcSEcCtD
Zidovudine—Hepatitis—Methotrexate—esophageal cancer	0.000145	0.00229	CcSEcCtD
Zidovudine—Arthralgia—Capecitabine—esophageal cancer	0.000145	0.00228	CcSEcCtD
Zidovudine—Chest pain—Capecitabine—esophageal cancer	0.000145	0.00228	CcSEcCtD
Zidovudine—Myalgia—Capecitabine—esophageal cancer	0.000145	0.00228	CcSEcCtD
Zidovudine—Pharyngitis—Methotrexate—esophageal cancer	0.000144	0.00228	CcSEcCtD
Zidovudine—Anxiety—Capecitabine—esophageal cancer	0.000144	0.00228	CcSEcCtD
Zidovudine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000144	0.00227	CcSEcCtD
Zidovudine—Urinary tract disorder—Methotrexate—esophageal cancer	0.000143	0.00227	CcSEcCtD
Zidovudine—Discomfort—Capecitabine—esophageal cancer	0.000143	0.00226	CcSEcCtD
Zidovudine—Urethral disorder—Methotrexate—esophageal cancer	0.000142	0.00225	CcSEcCtD
Zidovudine—Confusional state—Capecitabine—esophageal cancer	0.00014	0.00221	CcSEcCtD
Zidovudine—Oedema—Capecitabine—esophageal cancer	0.000139	0.00219	CcSEcCtD
Zidovudine—Erythema multiforme—Methotrexate—esophageal cancer	0.000137	0.00217	CcSEcCtD
Zidovudine—Shock—Capecitabine—esophageal cancer	0.000136	0.00215	CcSEcCtD
Zidovudine—Nervous system disorder—Capecitabine—esophageal cancer	0.000136	0.00215	CcSEcCtD
Zidovudine—Thrombocytopenia—Capecitabine—esophageal cancer	0.000136	0.00214	CcSEcCtD
Zidovudine—Asthenia—Cisplatin—esophageal cancer	0.000135	0.00213	CcSEcCtD
Zidovudine—Cardiac disorder—Methotrexate—esophageal cancer	0.000135	0.00213	CcSEcCtD
Zidovudine—Skin disorder—Capecitabine—esophageal cancer	0.000135	0.00213	CcSEcCtD
Zidovudine—Hyperhidrosis—Capecitabine—esophageal cancer	0.000134	0.00212	CcSEcCtD
Zidovudine—Anorexia—Capecitabine—esophageal cancer	0.000132	0.00209	CcSEcCtD
Zidovudine—Mediastinal disorder—Methotrexate—esophageal cancer	0.000131	0.00207	CcSEcCtD
Zidovudine—Chills—Methotrexate—esophageal cancer	0.00013	0.00206	CcSEcCtD
Zidovudine—Diarrhoea—Cisplatin—esophageal cancer	0.000129	0.00203	CcSEcCtD
Zidovudine—Mental disorder—Methotrexate—esophageal cancer	0.000127	0.00201	CcSEcCtD
Zidovudine—Malnutrition—Methotrexate—esophageal cancer	0.000126	0.002	CcSEcCtD
Zidovudine—Erythema—Methotrexate—esophageal cancer	0.000126	0.002	CcSEcCtD
Zidovudine—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000126	0.00199	CcSEcCtD
Zidovudine—Insomnia—Capecitabine—esophageal cancer	0.000125	0.00198	CcSEcCtD
Zidovudine—ABCB1—lung—esophageal cancer	0.000125	0.0054	CbGeAlD
Zidovudine—Paraesthesia—Capecitabine—esophageal cancer	0.000124	0.00197	CcSEcCtD
Zidovudine—Dysgeusia—Methotrexate—esophageal cancer	0.000124	0.00196	CcSEcCtD
Zidovudine—Dyspnoea—Capecitabine—esophageal cancer	0.000124	0.00195	CcSEcCtD
Zidovudine—Back pain—Methotrexate—esophageal cancer	0.000122	0.00193	CcSEcCtD
Zidovudine—Dyspepsia—Capecitabine—esophageal cancer	0.000122	0.00193	CcSEcCtD
Zidovudine—Decreased appetite—Capecitabine—esophageal cancer	0.00012	0.0019	CcSEcCtD
Zidovudine—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.00012	0.00189	CcSEcCtD
Zidovudine—Vomiting—Cisplatin—esophageal cancer	0.00012	0.00189	CcSEcCtD
Zidovudine—Fatigue—Capecitabine—esophageal cancer	0.000119	0.00189	CcSEcCtD
Zidovudine—Rash—Cisplatin—esophageal cancer	0.000119	0.00187	CcSEcCtD
Zidovudine—Pain—Capecitabine—esophageal cancer	0.000118	0.00187	CcSEcCtD
Zidovudine—Constipation—Capecitabine—esophageal cancer	0.000118	0.00187	CcSEcCtD
Zidovudine—Dermatitis—Cisplatin—esophageal cancer	0.000118	0.00187	CcSEcCtD
Zidovudine—Ill-defined disorder—Methotrexate—esophageal cancer	0.000117	0.00185	CcSEcCtD
Zidovudine—Anaemia—Methotrexate—esophageal cancer	0.000117	0.00185	CcSEcCtD
Zidovudine—Feeling abnormal—Capecitabine—esophageal cancer	0.000114	0.0018	CcSEcCtD
Zidovudine—Malaise—Methotrexate—esophageal cancer	0.000114	0.0018	CcSEcCtD
Zidovudine—Vertigo—Methotrexate—esophageal cancer	0.000114	0.00179	CcSEcCtD
Zidovudine—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000113	0.00179	CcSEcCtD
Zidovudine—Leukopenia—Methotrexate—esophageal cancer	0.000113	0.00179	CcSEcCtD
Zidovudine—Nausea—Cisplatin—esophageal cancer	0.000112	0.00176	CcSEcCtD
Zidovudine—Cough—Methotrexate—esophageal cancer	0.00011	0.00174	CcSEcCtD
Zidovudine—Urticaria—Capecitabine—esophageal cancer	0.00011	0.00174	CcSEcCtD
Zidovudine—Body temperature increased—Capecitabine—esophageal cancer	0.00011	0.00173	CcSEcCtD
Zidovudine—Abdominal pain—Capecitabine—esophageal cancer	0.00011	0.00173	CcSEcCtD
Zidovudine—Convulsion—Methotrexate—esophageal cancer	0.00011	0.00173	CcSEcCtD
Zidovudine—Chest pain—Methotrexate—esophageal cancer	0.000108	0.0017	CcSEcCtD
Zidovudine—Myalgia—Methotrexate—esophageal cancer	0.000108	0.0017	CcSEcCtD
Zidovudine—Arthralgia—Methotrexate—esophageal cancer	0.000108	0.0017	CcSEcCtD
Zidovudine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000107	0.00169	CcSEcCtD
Zidovudine—Discomfort—Methotrexate—esophageal cancer	0.000106	0.00168	CcSEcCtD
Zidovudine—Confusional state—Methotrexate—esophageal cancer	0.000104	0.00164	CcSEcCtD
Zidovudine—Anaphylactic shock—Methotrexate—esophageal cancer	0.000103	0.00163	CcSEcCtD
Zidovudine—Nervous system disorder—Methotrexate—esophageal cancer	0.000101	0.0016	CcSEcCtD
Zidovudine—Thrombocytopenia—Methotrexate—esophageal cancer	0.000101	0.0016	CcSEcCtD
Zidovudine—Skin disorder—Methotrexate—esophageal cancer	0.0001	0.00158	CcSEcCtD
Zidovudine—Hyperhidrosis—Methotrexate—esophageal cancer	9.97e-05	0.00158	CcSEcCtD
Zidovudine—Asthenia—Capecitabine—esophageal cancer	9.94e-05	0.00157	CcSEcCtD
Zidovudine—Anorexia—Methotrexate—esophageal cancer	9.83e-05	0.00155	CcSEcCtD
Zidovudine—Pruritus—Capecitabine—esophageal cancer	9.8e-05	0.00155	CcSEcCtD
Zidovudine—Diarrhoea—Capecitabine—esophageal cancer	9.48e-05	0.0015	CcSEcCtD
Zidovudine—Musculoskeletal discomfort—Methotrexate—esophageal cancer	9.4e-05	0.00148	CcSEcCtD
Zidovudine—Insomnia—Methotrexate—esophageal cancer	9.33e-05	0.00147	CcSEcCtD
Zidovudine—Paraesthesia—Methotrexate—esophageal cancer	9.26e-05	0.00146	CcSEcCtD
Zidovudine—Dyspnoea—Methotrexate—esophageal cancer	9.2e-05	0.00145	CcSEcCtD
Zidovudine—Somnolence—Methotrexate—esophageal cancer	9.17e-05	0.00145	CcSEcCtD
Zidovudine—Dizziness—Capecitabine—esophageal cancer	9.16e-05	0.00145	CcSEcCtD
Zidovudine—Dyspepsia—Methotrexate—esophageal cancer	9.08e-05	0.00143	CcSEcCtD
Zidovudine—Decreased appetite—Methotrexate—esophageal cancer	8.97e-05	0.00142	CcSEcCtD
Zidovudine—Gastrointestinal disorder—Methotrexate—esophageal cancer	8.91e-05	0.00141	CcSEcCtD
Zidovudine—Fatigue—Methotrexate—esophageal cancer	8.89e-05	0.0014	CcSEcCtD
Zidovudine—Pain—Methotrexate—esophageal cancer	8.82e-05	0.00139	CcSEcCtD
Zidovudine—Vomiting—Capecitabine—esophageal cancer	8.81e-05	0.00139	CcSEcCtD
Zidovudine—Rash—Capecitabine—esophageal cancer	8.74e-05	0.00138	CcSEcCtD
Zidovudine—Dermatitis—Capecitabine—esophageal cancer	8.73e-05	0.00138	CcSEcCtD
Zidovudine—Headache—Capecitabine—esophageal cancer	8.68e-05	0.00137	CcSEcCtD
Zidovudine—ABCB1—lymph node—esophageal cancer	8.54e-05	0.00369	CbGeAlD
Zidovudine—Feeling abnormal—Methotrexate—esophageal cancer	8.5e-05	0.00134	CcSEcCtD
Zidovudine—Gastrointestinal pain—Methotrexate—esophageal cancer	8.43e-05	0.00133	CcSEcCtD
Zidovudine—Nausea—Capecitabine—esophageal cancer	8.23e-05	0.0013	CcSEcCtD
Zidovudine—Urticaria—Methotrexate—esophageal cancer	8.19e-05	0.00129	CcSEcCtD
Zidovudine—Body temperature increased—Methotrexate—esophageal cancer	8.15e-05	0.00129	CcSEcCtD
Zidovudine—Abdominal pain—Methotrexate—esophageal cancer	8.15e-05	0.00129	CcSEcCtD
Zidovudine—Asthenia—Methotrexate—esophageal cancer	7.4e-05	0.00117	CcSEcCtD
Zidovudine—Pruritus—Methotrexate—esophageal cancer	7.3e-05	0.00115	CcSEcCtD
Zidovudine—Diarrhoea—Methotrexate—esophageal cancer	7.06e-05	0.00111	CcSEcCtD
Zidovudine—Dizziness—Methotrexate—esophageal cancer	6.82e-05	0.00108	CcSEcCtD
Zidovudine—Vomiting—Methotrexate—esophageal cancer	6.56e-05	0.00104	CcSEcCtD
Zidovudine—Rash—Methotrexate—esophageal cancer	6.5e-05	0.00103	CcSEcCtD
Zidovudine—Dermatitis—Methotrexate—esophageal cancer	6.5e-05	0.00103	CcSEcCtD
Zidovudine—Headache—Methotrexate—esophageal cancer	6.46e-05	0.00102	CcSEcCtD
Zidovudine—Nausea—Methotrexate—esophageal cancer	6.13e-05	0.000968	CcSEcCtD
Zidovudine—CYP2A6—Metabolism—GSTT1—esophageal cancer	9.29e-06	7.84e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	9.24e-06	7.79e-05	CbGpPWpGaD
Zidovudine—ALB—Transmembrane transport of small molecules—HMOX1—esophageal cancer	9.21e-06	7.77e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—TYMP—esophageal cancer	9.05e-06	7.63e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—TYMP—esophageal cancer	9e-06	7.59e-05	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	8.88e-06	7.49e-05	CbGpPWpGaD
Zidovudine—ALB—Transmembrane transport of small molecules—ABCB1—esophageal cancer	8.84e-06	7.46e-05	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—CREBBP—esophageal cancer	8.82e-06	7.44e-05	CbGpPWpGaD
Zidovudine—ABCC5—Disease—ERBB2—esophageal cancer	8.82e-06	7.44e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—CYP26A1—esophageal cancer	8.8e-06	7.43e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—PLCE1—esophageal cancer	8.79e-06	7.41e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—ADH7—esophageal cancer	8.79e-06	7.41e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—CYP26A1—esophageal cancer	8.75e-06	7.38e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—PTGS1—esophageal cancer	8.71e-06	7.34e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—ENO1—esophageal cancer	8.71e-06	7.34e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	8.69e-06	7.33e-05	CbGpPWpGaD
Zidovudine—ABCC5—Disease—PTGS2—esophageal cancer	8.63e-06	7.28e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—ALOX15—esophageal cancer	8.58e-06	7.24e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—PSME2—esophageal cancer	8.58e-06	7.24e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—PSME1—esophageal cancer	8.58e-06	7.24e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—ALOX15—esophageal cancer	8.53e-06	7.19e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—ADH1B—esophageal cancer	8.45e-06	7.13e-05	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—PIK3CA—esophageal cancer	8.44e-06	7.12e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—ADH1B—esophageal cancer	8.25e-06	6.96e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—TPI1—esophageal cancer	8.18e-06	6.9e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—GSTO1—esophageal cancer	8.18e-06	6.9e-05	CbGpPWpGaD
Zidovudine—TERT—Signaling Pathways—TP53—esophageal cancer	8.17e-06	6.89e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—CYP1B1—esophageal cancer	8.15e-06	6.87e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—TPI1—esophageal cancer	8.14e-06	6.86e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—GSTO1—esophageal cancer	8.14e-06	6.86e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—TYMP—esophageal cancer	8.08e-06	6.81e-05	CbGpPWpGaD
Zidovudine—ABCB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	8.07e-06	6.81e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—CYP1B1—esophageal cancer	8.06e-06	6.8e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—BLVRB—esophageal cancer	8.02e-06	6.76e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—SLC52A3—esophageal cancer	8.02e-06	6.76e-05	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—NOS3—esophageal cancer	7.9e-06	6.66e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—TYMP—esophageal cancer	7.88e-06	6.65e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—CYP26A1—esophageal cancer	7.86e-06	6.63e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—ALDOB—esophageal cancer	7.85e-06	6.62e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—ALDOB—esophageal cancer	7.8e-06	6.58e-05	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	7.74e-06	6.53e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—ADH1B—esophageal cancer	7.71e-06	6.5e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—CYP26A1—esophageal cancer	7.67e-06	6.47e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—CYP19A1—esophageal cancer	7.66e-06	6.46e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—ALOX15—esophageal cancer	7.66e-06	6.46e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—NOS2—esophageal cancer	7.6e-06	6.41e-05	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—PIK3CA—esophageal cancer	7.6e-06	6.41e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—CYP19A1—esophageal cancer	7.58e-06	6.39e-05	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	7.57e-06	6.38e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—GAPDH—esophageal cancer	7.55e-06	6.37e-05	CbGpPWpGaD
Zidovudine—ABCC5—Disease—CDKN1A—esophageal cancer	7.54e-06	6.36e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—GAPDH—esophageal cancer	7.51e-06	6.33e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—CRABP1—esophageal cancer	7.49e-06	6.31e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—ALOX15—esophageal cancer	7.47e-06	6.3e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—CRABP1—esophageal cancer	7.44e-06	6.28e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—CYP1B1—esophageal cancer	7.4e-06	6.24e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—TYMP—esophageal cancer	7.37e-06	6.21e-05	CbGpPWpGaD
Zidovudine—ABCC4—Hemostasis—TP53—esophageal cancer	7.35e-06	6.2e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—TPI1—esophageal cancer	7.31e-06	6.16e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—GSTO1—esophageal cancer	7.31e-06	6.16e-05	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—PTGS2—esophageal cancer	7.22e-06	6.09e-05	CbGpPWpGaD
Zidovudine—ABCC5—Disease—EP300—esophageal cancer	7.17e-06	6.05e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—CYP26A1—esophageal cancer	7.16e-06	6.04e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—GSTO1—esophageal cancer	7.13e-06	6.01e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—TPI1—esophageal cancer	7.13e-06	6.01e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—GNG7—esophageal cancer	7.12e-06	6.01e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—GNG7—esophageal cancer	7.08e-06	5.97e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—ALDOB—esophageal cancer	7e-06	5.91e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—HMOX1—esophageal cancer	6.99e-06	5.9e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—ALOX15—esophageal cancer	6.98e-06	5.89e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—CYP19A1—esophageal cancer	6.96e-06	5.87e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—HMOX1—esophageal cancer	6.92e-06	5.84e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—ALDOB—esophageal cancer	6.84e-06	5.77e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—CREBBP—esophageal cancer	6.82e-06	5.76e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—CA1—esophageal cancer	6.82e-06	5.75e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—SLC10A2—esophageal cancer	6.82e-06	5.75e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—GAPDH—esophageal cancer	6.74e-06	5.69e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—ABCB1—esophageal cancer	6.71e-06	5.66e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—CRABP1—esophageal cancer	6.68e-06	5.64e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—ALDH2—esophageal cancer	6.67e-06	5.63e-05	CbGpPWpGaD
Zidovudine—ALB—Platelet activation, signaling and aggregation—PIK3CA—esophageal cancer	6.67e-06	5.63e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—GSTO1—esophageal cancer	6.66e-06	5.62e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—TPI1—esophageal cancer	6.66e-06	5.62e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—ABCB1—esophageal cancer	6.64e-06	5.6e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—ALDH2—esophageal cancer	6.63e-06	5.6e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—GAPDH—esophageal cancer	6.58e-06	5.55e-05	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	6.57e-06	5.54e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—CRABP1—esophageal cancer	6.52e-06	5.5e-05	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—CREBBP—esophageal cancer	6.5e-06	5.49e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—ALDOB—esophageal cancer	6.39e-06	5.39e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—GNG7—esophageal cancer	6.36e-06	5.36e-05	CbGpPWpGaD
Zidovudine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	6.35e-06	5.36e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—HMOX1—esophageal cancer	6.35e-06	5.36e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—GSTT1—esophageal cancer	6.35e-06	5.35e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—GSTT1—esophageal cancer	6.31e-06	5.32e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—CYP2A6—esophageal cancer	6.27e-06	5.29e-05	CbGpPWpGaD
Zidovudine—ABCC5—Disease—MYC—esophageal cancer	6.25e-06	5.27e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	6.25e-06	5.27e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—CYP2A6—esophageal cancer	6.24e-06	5.26e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—CA2—esophageal cancer	6.24e-06	5.26e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	6.21e-06	5.24e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—GNG7—esophageal cancer	6.2e-06	5.23e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—GAPDH—esophageal cancer	6.15e-06	5.18e-05	CbGpPWpGaD
Zidovudine—ABCC5—Disease—EGFR—esophageal cancer	6.11e-06	5.16e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—NOS3—esophageal cancer	6.11e-06	5.15e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—ABCB1—esophageal cancer	6.1e-06	5.14e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—CRABP1—esophageal cancer	6.09e-06	5.14e-05	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—EP300—esophageal cancer	6.01e-06	5.07e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—ALDH2—esophageal cancer	5.96e-06	5.02e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—ENO1—esophageal cancer	5.95e-06	5.02e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—PTGS1—esophageal cancer	5.95e-06	5.02e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—ENO1—esophageal cancer	5.91e-06	4.99e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—PTGS1—esophageal cancer	5.91e-06	4.99e-05	CbGpPWpGaD
Zidovudine—ALB—Transmembrane transport of small molecules—CREBBP—esophageal cancer	5.91e-06	4.98e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—PSME1—esophageal cancer	5.86e-06	4.94e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—PSME2—esophageal cancer	5.86e-06	4.94e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—PSME1—esophageal cancer	5.83e-06	4.91e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—PSME2—esophageal cancer	5.83e-06	4.91e-05	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—NOS3—esophageal cancer	5.82e-06	4.91e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—ALDH2—esophageal cancer	5.81e-06	4.9e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PLCE1—esophageal cancer	5.8e-06	4.89e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—ADH7—esophageal cancer	5.8e-06	4.89e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—GNG7—esophageal cancer	5.79e-06	4.89e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—GSTT1—esophageal cancer	5.66e-06	4.78e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—CYP2A6—esophageal cancer	5.6e-06	4.72e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	5.58e-06	4.7e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—GSTT1—esophageal cancer	5.53e-06	4.66e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—CYP2A6—esophageal cancer	5.46e-06	4.61e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—ALDH2—esophageal cancer	5.43e-06	4.58e-05	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—PTGS2—esophageal cancer	5.33e-06	4.49e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—PTGS1—esophageal cancer	5.31e-06	4.48e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—ENO1—esophageal cancer	5.31e-06	4.48e-05	CbGpPWpGaD
Zidovudine—ABCC5—Disease—PIK3CA—esophageal cancer	5.31e-06	4.48e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—PSME1—esophageal cancer	5.23e-06	4.41e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—PSME2—esophageal cancer	5.23e-06	4.41e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—PTGS1—esophageal cancer	5.18e-06	4.37e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—ENO1—esophageal cancer	5.18e-06	4.37e-05	CbGpPWpGaD
Zidovudine—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	5.18e-06	4.37e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—GSTT1—esophageal cancer	5.16e-06	4.36e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	5.12e-06	4.32e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—CYP2A6—esophageal cancer	5.11e-06	4.31e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—PSME2—esophageal cancer	5.1e-06	4.31e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—PSME1—esophageal cancer	5.1e-06	4.31e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	5.09e-06	4.29e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	5.09e-06	4.29e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—ADH1B—esophageal cancer	5.08e-06	4.29e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—CYP1B1—esophageal cancer	5.06e-06	4.26e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—CYP1B1—esophageal cancer	5.03e-06	4.24e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—TYMP—esophageal cancer	4.86e-06	4.1e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—PTGS1—esophageal cancer	4.84e-06	4.08e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—ENO1—esophageal cancer	4.84e-06	4.08e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—PSME1—esophageal cancer	4.77e-06	4.02e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—PSME2—esophageal cancer	4.77e-06	4.02e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—CYP19A1—esophageal cancer	4.75e-06	4.01e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—CYP19A1—esophageal cancer	4.73e-06	3.99e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—CYP26A1—esophageal cancer	4.73e-06	3.99e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—EP300—esophageal cancer	4.65e-06	3.92e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—ALOX15—esophageal cancer	4.6e-06	3.88e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	4.57e-06	3.85e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—CYP1B1—esophageal cancer	4.51e-06	3.81e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—CREBBP—esophageal cancer	4.48e-06	3.78e-05	CbGpPWpGaD
Zidovudine—ABCC5—Metabolism—PIK3CA—esophageal cancer	4.44e-06	3.75e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—CREBBP—esophageal cancer	4.44e-06	3.74e-05	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—EP300—esophageal cancer	4.43e-06	3.74e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—CYP1B1—esophageal cancer	4.41e-06	3.72e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—TPI1—esophageal cancer	4.39e-06	3.71e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—GSTO1—esophageal cancer	4.39e-06	3.71e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—HMOX1—esophageal cancer	4.34e-06	3.66e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—HMOX1—esophageal cancer	4.31e-06	3.64e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	4.26e-06	3.59e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—CYP19A1—esophageal cancer	4.24e-06	3.58e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	4.23e-06	3.57e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—ALDOB—esophageal cancer	4.21e-06	3.55e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	4.16e-06	3.51e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—ABCB1—esophageal cancer	4.16e-06	3.51e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—CYP19A1—esophageal cancer	4.14e-06	3.49e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—ABCB1—esophageal cancer	4.14e-06	3.49e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—CYP1B1—esophageal cancer	4.12e-06	3.47e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—CREBBP—esophageal cancer	4.07e-06	3.44e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—GAPDH—esophageal cancer	4.05e-06	3.42e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—CRABP1—esophageal cancer	4.02e-06	3.39e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—NOS3—esophageal cancer	4.01e-06	3.39e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—NOS3—esophageal cancer	3.97e-06	3.35e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—HMOX1—esophageal cancer	3.87e-06	3.27e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—CYP19A1—esophageal cancer	3.87e-06	3.26e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—GNG7—esophageal cancer	3.82e-06	3.22e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	3.8e-06	3.2e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—HMOX1—esophageal cancer	3.78e-06	3.19e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—ABCB1—esophageal cancer	3.72e-06	3.13e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—PTGS2—esophageal cancer	3.67e-06	3.1e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—NOS3—esophageal cancer	3.65e-06	3.08e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—PTGS2—esophageal cancer	3.63e-06	3.07e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—ALDH2—esophageal cancer	3.58e-06	3.02e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—HMOX1—esophageal cancer	3.53e-06	2.98e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	3.46e-06	2.92e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—PIK3CA—esophageal cancer	3.44e-06	2.9e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—GSTT1—esophageal cancer	3.41e-06	2.87e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—ABCB1—esophageal cancer	3.39e-06	2.86e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—CYP2A6—esophageal cancer	3.37e-06	2.84e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—PTGS2—esophageal cancer	3.34e-06	2.81e-05	CbGpPWpGaD
Zidovudine—ALB—Hemostasis—TP53—esophageal cancer	3.33e-06	2.81e-05	CbGpPWpGaD
Zidovudine—UGT2B7—Metabolism—PIK3CA—esophageal cancer	3.28e-06	2.76e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—ENO1—esophageal cancer	3.19e-06	2.69e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PTGS1—esophageal cancer	3.19e-06	2.69e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	3.15e-06	2.66e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PSME2—esophageal cancer	3.15e-06	2.65e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PSME1—esophageal cancer	3.15e-06	2.65e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	3.13e-06	2.64e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—EP300—esophageal cancer	3.05e-06	2.58e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—EP300—esophageal cancer	3.02e-06	2.55e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.81e-06	2.37e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—CREBBP—esophageal cancer	2.78e-06	2.35e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—EP300—esophageal cancer	2.77e-06	2.34e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—CREBBP—esophageal cancer	2.77e-06	2.33e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—CYP1B1—esophageal cancer	2.71e-06	2.29e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.56e-06	2.16e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—CYP19A1—esophageal cancer	2.55e-06	2.15e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—NOS3—esophageal cancer	2.49e-06	2.1e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—CREBBP—esophageal cancer	2.48e-06	2.1e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—NOS3—esophageal cancer	2.48e-06	2.09e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—CREBBP—esophageal cancer	2.42e-06	2.04e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—HMOX1—esophageal cancer	2.33e-06	1.96e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—PTGS2—esophageal cancer	2.28e-06	1.92e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—PTGS2—esophageal cancer	2.27e-06	1.91e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—CREBBP—esophageal cancer	2.26e-06	1.91e-05	CbGpPWpGaD
Zidovudine—ABCG2—Metabolism—PIK3CA—esophageal cancer	2.26e-06	1.91e-05	CbGpPWpGaD
Zidovudine—SLC22A2—Metabolism—PIK3CA—esophageal cancer	2.24e-06	1.89e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—ABCB1—esophageal cancer	2.23e-06	1.89e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—NOS3—esophageal cancer	2.22e-06	1.88e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—NOS3—esophageal cancer	2.17e-06	1.83e-05	CbGpPWpGaD
Zidovudine—CYP2A6—Metabolism—PIK3CA—esophageal cancer	2.05e-06	1.73e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—PTGS2—esophageal cancer	2.03e-06	1.72e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—NOS3—esophageal cancer	2.03e-06	1.71e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—PTGS2—esophageal cancer	1.99e-06	1.67e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—EP300—esophageal cancer	1.9e-06	1.6e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—EP300—esophageal cancer	1.88e-06	1.59e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—PTGS2—esophageal cancer	1.85e-06	1.56e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—EP300—esophageal cancer	1.69e-06	1.43e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—EP300—esophageal cancer	1.65e-06	1.39e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—EP300—esophageal cancer	1.54e-06	1.3e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—CREBBP—esophageal cancer	1.49e-06	1.26e-05	CbGpPWpGaD
Zidovudine—CYP2C8—Metabolism—PIK3CA—esophageal cancer	1.4e-06	1.18e-05	CbGpPWpGaD
Zidovudine—ALB—Metabolism—PIK3CA—esophageal cancer	1.39e-06	1.18e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—NOS3—esophageal cancer	1.34e-06	1.13e-05	CbGpPWpGaD
Zidovudine—CYP2C19—Metabolism—PIK3CA—esophageal cancer	1.25e-06	1.06e-05	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PTGS2—esophageal cancer	1.22e-06	1.03e-05	CbGpPWpGaD
Zidovudine—ABCB1—Metabolism—PIK3CA—esophageal cancer	1.22e-06	1.03e-05	CbGpPWpGaD
Zidovudine—CYP2C9—Metabolism—PIK3CA—esophageal cancer	1.14e-06	9.62e-06	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—EP300—esophageal cancer	1.02e-06	8.58e-06	CbGpPWpGaD
Zidovudine—CYP3A4—Metabolism—PIK3CA—esophageal cancer	7.53e-07	6.35e-06	CbGpPWpGaD
